Robert Bird

2.9k total citations
88 papers, 1.9k citations indexed

About

Robert Bird is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Robert Bird has authored 88 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 18 papers in Genetics and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Robert Bird's work include Platelet Disorders and Treatments (18 papers), Blood groups and transfusion (11 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Robert Bird is often cited by papers focused on Platelet Disorders and Treatments (18 papers), Blood groups and transfusion (11 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Robert Bird collaborates with scholars based in Australia, United Kingdom and United States. Robert Bird's co-authors include Rebecca Adams, P. Swift, Dan Siskind, Hannah Myles, Nicholas Myles, J. F. Hutton, G. G. Rooney, Matthew Large, Cherrie Galletly and Steve Kisely and has published in prestigious journals such as Nature, Blood and PLoS ONE.

In The Last Decade

Robert Bird

85 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Bird Australia 25 462 263 250 244 232 88 1.9k
Jun Ho Jang South Korea 28 953 2.1× 532 2.0× 269 1.1× 321 1.3× 134 0.6× 186 2.9k
Thomas Groß United States 28 140 0.3× 176 0.7× 391 1.6× 124 0.5× 76 0.3× 71 3.2k
James M. Peterson United States 30 188 0.4× 89 0.3× 184 0.7× 828 3.4× 69 0.3× 69 3.8k
Karin Andersson Sweden 28 68 0.1× 341 1.3× 144 0.6× 281 1.2× 121 0.5× 77 2.1k
P. Burke Ireland 30 155 0.3× 62 0.2× 84 0.3× 187 0.8× 164 0.7× 158 2.8k
Andrew Goodwin United States 28 159 0.3× 236 0.9× 239 1.0× 85 0.3× 38 0.2× 118 2.8k
Kyoko Takeuchi Japan 22 330 0.7× 157 0.6× 95 0.4× 397 1.6× 32 0.1× 98 1.8k
Paul Gordon United States 18 69 0.1× 43 0.2× 177 0.7× 199 0.8× 184 0.8× 70 1.3k
Shigeo Hara Japan 25 162 0.4× 157 0.6× 365 1.5× 265 1.1× 25 0.1× 251 2.4k
Eun Young Lee South Korea 37 389 0.8× 938 3.6× 1.0k 4.0× 567 2.3× 94 0.4× 187 5.5k

Countries citing papers authored by Robert Bird

Since Specialization
Citations

This map shows the geographic impact of Robert Bird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bird more than expected).

Fields of papers citing papers by Robert Bird

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Bird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bird. The network helps show where Robert Bird may publish in the future.

Co-authorship network of co-authors of Robert Bird

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Bird. A scholar is included among the top collaborators of Robert Bird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Bird. Robert Bird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castells, Mariana, C. Bulaï Livideanu, Olivier Hermine, et al.. (2025). HARBOR: An Ongoing Phase 2/3 Study of Elenestinib in Patients With Indolent Systemic Mastocytosis. Journal of Allergy and Clinical Immunology. 155(2). AB170–AB170. 1 indexed citations
2.
Kuter, David J., Jiřı́ Mayer, Ross Baker, et al.. (2024). Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood Advances. 8(7). 1715–1724. 11 indexed citations
3.
Biswas, Raaj Kishore, Vivien Chen, Helen Crowther, et al.. (2022). Treatment of immune thrombocytopenia in Australian adults: A multicenter retrospective observational study. Research and Practice in Thrombosis and Haemostasis. 6(6). e12792–e12792. 2 indexed citations
4.
Nath, Karthik, Soi Cheng Law, Muhammed B. Sabdia, et al.. (2021). Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma. Blood Advances. 5(12). 2644–2649. 12 indexed citations
5.
Barras, Michael, et al.. (2020). A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic Surgery. Drugs. 80(18). 1889–1899. 9 indexed citations
6.
Myles, Nicholas, Hannah Myles, Matthew Large, et al.. (2019). A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia. Australian & New Zealand Journal of Psychiatry. 53(5). 403–412. 44 indexed citations
7.
Vari, Frank, Colm Keane, Mark Hertzberg, et al.. (2018). Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL. Blood. 131(16). 1809–1819. 231 indexed citations
8.
Myles, Nicholas, Hannah Myles, Matthew Large, et al.. (2018). Meta‐analysis examining the epidemiology of clozapine‐associated neutropenia. Acta Psychiatrica Scandinavica. 138(2). 101–109. 125 indexed citations
9.
McQuilten, Zoe, Amanda J. Zatta, Nick Andrianopoulos, et al.. (2016). Evaluation of clinical coding data to determine causes of critical bleeding in patients receiving massive transfusion: a bi‐national, multicentre, cross‐sectional study. Transfusion Medicine. 27(2). 114–121. 7 indexed citations
10.
Marx, Wolfgang, Alexandra McCarthy, Robert Bird, et al.. (2015). The effect of ginger (Zingiber officinale) on platelet aggregation: A systematic literature review. Bond University Research Portal (Bond University). 7 indexed citations
11.
Fraser, John F., et al.. (2012). Tracking ecmo induced changes to Haemostasis with Rotem (r) and Multiplate (r) analyser in an Ovine model. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
12.
Bird, Robert, Melita Kenealy, Cecily Forsyth, et al.. (2012). When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload?. Internal Medicine Journal. 42(4). 450–455. 9 indexed citations
13.
Mollee, Peter, Jill Tate, Kirk Morris, et al.. (2010). Survival and prognostic factors amongst Australian patients with AL amyloidosis. Amyloid. 17. 150–151. 1 indexed citations
14.
Grimmett, Karen, Mark Jones, Anthony K. Mills, et al.. (2010). Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemia. Internal Medicine Journal. 41(5). 408–415. 1 indexed citations
15.
Solano, C., et al.. (2010). A study of atypical APTT derivative curves on the ACL TOP coagulation analyser. International Journal of Laboratory Hematology. 33(1). 67–78. 37 indexed citations
17.
Wong, River Chun‐Wai, Emmanuel J. Favaloro, Stephen Adelstein, et al.. (2007). Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting. Pathology. 40(1). 58–63. 31 indexed citations
18.
Eikelboom, John W., Robert Bird, David Blythe, et al.. (2003). Recombinant activated factor VII for the treatment of life-threatening haemorrhage. Blood Coagulation & Fibrinolysis. 14(8). 713–717. 71 indexed citations
19.
Bird, Robert, et al.. (1986). Mechanistic studies on oxide catalysts. II. Reactions of 2-methylpropene on lanthana and zirconia. Proceedings of the Royal Society of London A Mathematical and Physical Sciences. 408(1835). 249–266.
20.
Bird, Robert, et al.. (1969). A Dual-Band Audio Limiter. Journal of the Audio Engineering Society. 17(6). 678–684. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026